Fructose-1,6-bisphosphatase 1 suppresses PPARα-mediated gene transcription and non-small-cell lung cancer progression

被引:0
|
作者
Shi, Rongkai [1 ,2 ]
Tao, Jingjing [1 ,2 ]
Jiang, Xiaoming [1 ,2 ]
Li, Min [1 ,2 ]
Zhu, Rongxuan [1 ,2 ]
Luo, Shudi [1 ,2 ]
Lu, Zhimin [1 ,2 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Zhejiang Prov Key Lab Pancreat Dis,Inst Translat M, Hangzhou 310029, Zhejiang, Peoples R China
[2] Zhejiang Univ, Canc Ctr, Hangzhou 310029, Zhejiang, Peoples R China
来源
AMERICAN JOURNAL OF CANCER RESEARCH | 2023年 / 13卷 / 10期
基金
浙江省自然科学基金; 中国国家自然科学基金;
关键词
FBP1; non -small cell lung cancer (NSCLC); glutamine deprivation; phosphorylation; O-GlcNAcylation; prognostic biomarker; PROMOTES; PHOSPHORYLATION; EXPRESSION; KINASE; GROWTH; PGK1;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Rapidly growing tumors often encounter energy stress, such as glutamine deficiency. However, how nor-mal and tumor cells differentially respond to glutamine deficiency remains largely unclear. Here, we demonstrate that glutamine deprivation activates PERK, which phosphorylates FBP1 at S170 and induces nuclear accumulation of FBP1. Nuclear FBP1 inhibits PPAR alpha-mediated beta-oxidation gene transcription in normal lung epithelial cells. In contrast, highly expressed OGT in non-small cell lung cancer (NSCLC) cells promotes FBP1 O-GlcNAcylation, which abrogates FBP1 phosphorylation and enhances beta-oxidation gene transcription to support cell proliferation under glutamine deficiency. In addition, FBP1 pS170 is negatively correlated with OGT expression in human NSCLC specimens, and low expression of FBP1 pS170 is associated with poor prognosis in NSCLC patients. These findings highlight the differential regulation of FBP1 in normal and NSCLC cells under glutamine deprivation and underscore the potential to target nuclear FBP1 for NSCLC treatment.
引用
收藏
页码:4742 / +
页数:15
相关论文
共 50 条
  • [21] Epigenetic regulation of Fructose-1,6-bisphosphatase 1 by host transcription factor Speckled 110 kDa during hepatitis B virus infection
    Sengupta, Isha
    Mondal, Payel
    Sengupta, Amrita
    Mondal, Atanu
    Singh, Vipin
    Adhikari, Swagata
    Dhang, Sinjini
    Roy, Siddhartha
    Das, Chandrima
    FEBS JOURNAL, 2022, 289 (21) : 6694 - 6713
  • [22] Fructose-1,6-bisphosphatase loss modulates STAT3-dependent expression of PD-L1 and cancer immunity
    Wang, Bo
    Zhou, Yingke
    Zhang, Jun
    Jin, Xin
    Wu, Heshui
    Huang, Haojie
    THERANOSTICS, 2020, 10 (03): : 1033 - 1045
  • [23] Fructose-1,6-bisphosphatase Inhibits ERK Activation and Bypasses Gemcitabine Resistance in Pancreatic Cancer by Blocking IQGAP1-MAPK Interaction
    Jin, Xin
    Pan, Yunqian
    Wang, Liguo
    Ma, Tao
    Zhang, Lizhi
    Tang, Amy H.
    Billadeau, Daniel D.
    Wu, Heshui
    Huang, Haojie
    CANCER RESEARCH, 2017, 77 (16) : 4328 - 4341
  • [24] WWOX gene may contribute to progression of non-small-cell lung cancer (NSCLC)
    Baykara, Onur
    Demirkaya, Ahmet
    Kaynak, Kamil
    Tanju, Serhan
    Toker, Alper
    Buyru, Nur
    TUMOR BIOLOGY, 2010, 31 (04) : 315 - 320
  • [25] Gene fusions in non-small-cell lung cancer
    Yang, Lu-Lu
    Wu, Yi-Long
    LUNG CANCER MANAGEMENT, 2012, 1 (04) : 283 - 292
  • [26] Murine double minute gene 2 (MDM2) promoted hepatocellular carcinoma (HCC) cell growth by targeting fructose-1,6-bisphosphatase (FBP1) for degradation
    Xu, Yao
    Wu, Bin
    Yang, Jing
    Zhang, Sheng
    Liu, Longgen
    Xu, Suobao
    Jiang, Jiakai
    BIOCELL, 2022, 46 (06) : 1483 - 1491
  • [27] Silencing HIPPI Suppresses Tumor Progression in Non-Small-Cell Lung Cancer by Inhibiting DNA Replication
    Xie, Guanghui
    Li, Yongwen
    Jiang, Yongjun
    Ye, Xian
    Tang, Jianfeng
    Chen, Jun
    ONCOTARGETS AND THERAPY, 2021, 14 : 3467 - 3480
  • [28] Fructose-1,6-bisphosphatase 2 represses cervical cancer progression via inhibiting aerobic glycolysis through promoting pyruvate kinase isozyme type M2 ubiquitination
    Wang, Bi
    Yuan, Yingnan
    Zou, Yin
    Qi, Zhengjun
    Huang, Guijia
    Liu, Yi
    Xia, Shan
    Huang, Yu
    Huang, Zhi
    ANTI-CANCER DRUGS, 2022, 33 (01) : E198 - E206
  • [29] Andrographolide suppresses non-small-cell lung cancer progression through induction of autophagy and antitumor immune response
    Wang, Xuan-Run
    Jiang, Ze-Bo
    Xu, Cong
    Meng, Wei-Yu
    Liu, Pei
    Zhang, Yi-Zhong
    Xie, Chun
    Xu, Jing-Yi
    Xie, Ya-Jia
    Liang, Tu-Liang
    Yan, Hao-Xin
    Fan, Xing-Xing
    Yao, Xiao-Jun
    Wu, Qi-Biao
    Leung, Elaine Lai-Han
    PHARMACOLOGICAL RESEARCH, 2022, 179
  • [30] Prognostic gene signatures for non-small-cell lung cancer
    Boutros, Paul C.
    Lau, Suzanne K.
    Pintilie, Melania
    Liu, Ni
    Shepherd, Frances A.
    Der, Sandy D.
    Tsao, Ming-Sound
    Penn, Linda Z.
    Jurisica, Igor
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (08) : 2824 - 2828